%title% HYRIMOZ (adalimumab-adaz) injection_alt %term%

Adalimumab-adaz is a tumor necrosis factor blocker. Adalimumab products bind specifically to TNF alpha and block its interaction with the p55 and p75 cell surface TNF receptors. Adalimumab products also lyse surface TNF expressing cells in vitro in the presence of complement.

The post HYRIMOZ (adalimumab-adaz) injection first appeared on Gafacom.